255 related articles for article (PubMed ID: 23701975)
1. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice.
Kang S; Roh YJ; Kim IB
Exp Eye Res; 2013 Jul; 112():125-33. PubMed ID: 23701975
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effect of ALS-L1023, an extract of Melissa officinalis L., on experimental choroidal neovascularization in mice.
Roh YJ; Jee D; Rho CR; Cho WK; Kang S
Clin Exp Ophthalmol; 2016; 44(1):43-51. PubMed ID: 26221970
[TBL] [Abstract][Full Text] [Related]
3. Effect of cediranib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in a mouse model of choroidal neovascularization.
Kang S; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Clin Exp Ophthalmol; 2013; 41(1):63-72. PubMed ID: 22594647
[TBL] [Abstract][Full Text] [Related]
4. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
5. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice.
Kang S; Roh CR; Cho WK; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Curr Eye Res; 2013 Jan; 38(1):119-27. PubMed ID: 23013553
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effects of topically administered multiple kinase inhibitor, motesanib (AMG 706), on experimental choroidal neovascularization in mice.
Rho CR; Kang S; Park KC; Yang KJ; Choi H; Cho WK
J Ocul Pharmacol Ther; 2015 Feb; 31(1):25-31. PubMed ID: 25255037
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib.
Chung EJ; Yoo S; Lim HJ; Byeon SH; Lee JH; Koh HJ
Br J Ophthalmol; 2009 Jul; 93(7):958-63. PubMed ID: 19028740
[TBL] [Abstract][Full Text] [Related]
9. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344.
Xie P; Kamei M; Suzuki M; Matsumura N; Nishida K; Sakimoto S; Sakaguchi H; Nishida K
PLoS One; 2011; 6(12):e28933. PubMed ID: 22205983
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic Effects of Doxazosin on Experimental Choroidal Neovascularization in Mice.
Guo J; Luo X; Liang J; Xiao M; Sun X
J Ocul Pharmacol Ther; 2017; 33(1):50-56. PubMed ID: 27992238
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
12. Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.
Campa C; Kasman I; Ye W; Lee WP; Fuh G; Ferrara N
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1178-83. PubMed ID: 18326747
[TBL] [Abstract][Full Text] [Related]
13. The Antiangiogenic Effects of Gold Nanoparticles on Experimental Choroidal Neovascularization in Mice.
Roh YJ; Rho CR; Cho WK; Kang S
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6561-6567. PubMed ID: 27918830
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
Wei X; Zhang T; Yao Y; Zeng S; Li M; Xiang H; Zhao C; Cao G; Li M; Wan R; Yang P; Yang J
Exp Eye Res; 2018 Mar; 168():2-11. PubMed ID: 29284110
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo.
Takahashi H; Tamaki Y; Ishii N; Oikawa N; Mizuguchi E; Francis JH; Inoue Y; Iriyama A; Obata R; Yanagi Y
Curr Eye Res; 2008 Nov; 33(11):1002-10. PubMed ID: 19085383
[TBL] [Abstract][Full Text] [Related]
17. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.
Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A
Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435
[TBL] [Abstract][Full Text] [Related]
18. Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.
Takeda A; Hata Y; Shiose S; Sassa Y; Honda M; Fujisawa K; Sakamoto T; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):765-72. PubMed ID: 12937991
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Zambarakji HJ; Nakazawa T; Connolly E; Lane AM; Mallemadugula S; Kaplan M; Michaud N; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2623-31. PubMed ID: 16723479
[TBL] [Abstract][Full Text] [Related]
20. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]